The earnings call reflected a mix of positive growth in membership and revenue, as well as high quality performance metrics. However, significant challenges were highlighted, including substantial medical margin losses, lowered financial guidance, and the need to exit certain partnerships. The negative financial adjustments and strategic exits suggest a challenging period ahead.
Company Guidance
During Agilon Health's Q3 2024 earnings call, the company updated its guidance amidst challenging conditions. MA membership saw a significant growth of 37% year-over-year, reaching 525,000 members, while total revenue increased by 28% to $1.45 billion. However, the medical margin reported a loss of $58 million, attributed to unfavorable trends in risk adjustment and medical expenses. Consequently, the full-year medical margin guidance was lowered to $225 million from a previous range of $400-450 million. Adjusted EBITDA also declined, showing a loss of $96 million for the quarter. The company announced strategic exits from certain partnerships, projected to reduce year-end membership by 45,000-75,000 and annualized revenue by $470-785 million. Despite these setbacks, Agilon remains optimistic, noting a 90% net tailwind from payer bids for 2025 and a projected addition of 45,000 members in the next year. The company also underscored its robust core business and strategic actions aimed at improving profitability and cash flow in the future.
MA Membership Growth
Medicare Advantage membership rose 37% year-over-year to 525,000 members due to stronger-than-expected growth in the same geography and expansion of the new partner class.
Revenue Increase
Total revenue grew 28% to $1.45 billion, driven by the expansion of the 2024 market class and organic growth in existing classes.
Quality Performance
The STARS scores for 2025 showed that every partner in the platform scored above the critical 4 STARS threshold, with the majority above 4.25 STARS.
---
Agilon Health (AGL) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AGL Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 07, 2024
$2.79
$1.84
-34.05%
Aug 06, 2024
$6.22
$5.64
-9.32%
May 07, 2024
$4.98
$5.19
+4.22%
Feb 27, 2024
$6.48
$6.36
-1.85%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Agilon Health (AGL) report earnings?
Agilon Health (AGL) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is Agilon Health (AGL) earnings time?
Agilon Health (AGL) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.